Göksel Sener

Prof. Göksel Sener


Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2006 in European Journal of Pharmacology
Verified
Journal Article
Closed access
GSGöksel Sener
Göksel Sener
EEEmel Ekşioğlu-Demiralp
Emel Ekşioğlu-Demiralp
MÇMustafa Çetiner
Mustafa Çetiner
FEFeriha Ercan
Feriha Ercan
BYBerrak Yegen
Berrak Yegen

1 December 2007 in Pulmonary Pharmacology & Therapeutics
Verified
Journal Article
Closed access
GSGöksel Sener
Göksel Sener
NTNurhayat Topaloğlu
Nurhayat Topaloğlu
AŞA. Özer Şehirli
A. Özer Şehirli
FEFeriha Ercan
Feriha Ercan
NGNursal Gedik
Nursal Gedik

1 July 2006 in Pharmacological Research
Verified
Journal Article
Closed access
GSGöksel Sener
Göksel Sener
OSO Sehirli
O Sehirli
AVA Veliogluogunc
A Veliogluogunc
SCS Cetinel
S Cetinel
NGN Gedik
N Gedik
BYBerrak Yegen
Berrak Yegen

1 January 2006 in Cell Biology and Toxicology
Verified
Journal Article
Closed access
PDF file
GSGöksel Sener
Göksel Sener
EEE. Ekşioğlu-Demiralp
E. Ekşioğlu-Demiralp
MÇM. Çetiner
M. Çetiner
FEF. Ercan
F. Ercan
SŞS. Şirvancı
S. Şirvancı
BYBerrak Yegen
Berrak Yegen

1 May 2004 in Journal of Cardiovascular Pharmacology
Verified
Journal Article
Closed access
GSGöksel Sener
Göksel Sener
KPKübra Paskaloğlu
Kübra Paskaloğlu
HŞHandan Şatiroglu
Handan Şatiroglu
IAInci Alican
Inci Alican
AKAyhan Kaçmaz
Ayhan Kaçmaz
ASAbdullah Sakarcan
Abdullah Sakarcan
Chronic renal failure (CRF) is associated with oxidative stress that promotes production of reactive oxygen species. L-Carnitine is a cofactor required for transport of long-chain fatty acids into the mitochondrial matrix. Recent research has shown that some clinical conditions (i.e., anorexia, chronic fatigue, coronary heart disease, diphtheria, hypoglycemia, and male infertility) benefit from exogenous supplementation of L-carnitine. The aim of this study was to examine the role of L-carnitine in protecting the aorta, heart, corpus cavernosum, and kidney tissues against oxidative damage in a rat model of CRF. Male Wistar albino rats were randomly assigned to either the CRF group or the sham-operated control group, which had received saline or L-carnitine (500 mg/kg, i.p.) for 4 weeks. CRF was evaluated by BUN and serum creatinine measurements. Aorta and corporeal tissues were used for contractility studies or stored along with heart and kidney tissues for the measurement of malondialdehyde (MDA) and glutathione (GSH) levels. Plasma MDA, GSH levels and erythrocyte superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GSH-Px) activities were also studied. In the CRF group, the contraction and the relaxation of aorta and corpus cavernosum samples decreased significantly compared with controls and were partially reversed by L-carnitine treatment. In the CRF group, there were significant increases in tissue MDA with marked reductions in GSH levels in all tissues and plasma compared with controls. In the plasma SOD, CAT and GSH-Px activities were also reduced. All these effects were reversed by L-carnitine as well. The increase in MDA level and the concomitant decrease in GSH level of tissues and plasma and also suppression of the antioxidant enzyme activities in plasma demonstrate that oxidative mechanisms are involved in CRF-induced tissue damage. L-carnitine, possibly via its free radical scavenging and antioxidant properties, ameliorates oxidative organ injury and CRF-induced dysfunction of the aorta and corpus cavernosum. These results suggest that L-carnitine supplementation may have some benefit in CRF patients.

17 October 2007 in Clinical and Experimental Pharmacology and Physiology
Verified
Journal Article
Closed access
PDF file
ÖŞÖzer Şehirli
Özer Şehirli
TSTarik Emre Sener
Tarik Emre Sener
ŞÇŞule Çetinel
Şule Çetinel
MYMeral Yüksel
Meral Yüksel
NGNursal Gedik
Nursal Gedik
GSGöksel Sener
Göksel Sener